{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:16:03Z","timestamp":1790496963868,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0668-5","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T13:19:03Z","timestamp":1501075143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8344-1300","authenticated-orcid":false,"given":"Stanislas","family":"Bataille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Sall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvon","family":"Berland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosra","family":"Mouelhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Burtey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"issue":"1","key":"668_CR1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","volume":"20","author":"O Moranne","year":"2009","unstructured":"Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, M'rad MB, Jacquot C, Houillier P, Stengel B, Fouqueray B, NephroTest Study Group. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol. 2009 Jan;20(1):164\u201371.","journal-title":"J Am Soc Nephrol"},{"key":"668_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"K Disease","year":"2013","unstructured":"Disease K, Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kidney Int Suppl"},{"key":"668_CR3","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1046\/j.1523-1755.2001.59780067.x","volume":"78","author":"IC Macdougall","year":"2001","unstructured":"Macdougall IC. Role of uremic toxins in exacerbating anemia in renal failure. Kidney Int Suppl. 2001 Feb;78:S67\u201372.","journal-title":"Kidney Int Suppl"},{"issue":"10","key":"668_CR4","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","volume":"23","author":"JL Babitt","year":"2012","unstructured":"Babitt JL. Lin HYMechanisms of anemia in CKD. J Am Soc Nephrol. 2012 Oct;23(10):1631\u20134.","journal-title":"J Am Soc Nephrol"},{"issue":"21","key":"668_CR5","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","volume":"361","author":"MA Pfeffer","year":"2009","unstructured":"Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R. TREAT investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009 Nov 19;361(21):2019\u201332.","journal-title":"N Engl J Med"},{"issue":"4","key":"668_CR6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ki.1991.88","volume":"39","author":"DS Kushner","year":"1991","unstructured":"Kushner DS, Beckman B, Nguyen L, Chen S, Della Santina C, Husserl F, Rice J, Fisher JW. Polyamines in the anemia of end-stage renal disease. Kidney Int. 1991 Apr;39(4):725\u201332.","journal-title":"Kidney Int"},{"key":"668_CR7","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/labinvest.2011.114","volume":"91","author":"CK Chiang","year":"2011","unstructured":"Chiang CK, Tanaka T, Inagi R, Fujita T, Nangaku M. Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner. Lab Investig. 2011;91:1564\u201371.","journal-title":"Lab Investig"},{"issue":"4","key":"668_CR8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ki.2013.133","volume":"84","author":"B Gondouin","year":"2013","unstructured":"Gondouin B, Cerini C, Dou L, Sall\u00e9e M, Duval-Sabatier A, Pletinck A, Calaf R, Lacroix R, Jourde-Chiche N, Poitevin S, Arnaud L, Vanholder R, Brunet P, Dignat-George F, Burtey S. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway. Kidney Int. 2013 Oct;84(4):733\u201344.","journal-title":"Kidney Int"},{"issue":"2","key":"668_CR9","doi-asserted-by":"crossref","first-page":"C142","DOI":"10.1152\/ajpcell.00172.2015","volume":"310","author":"H Asai","year":"2016","unstructured":"Asai H, Hirata J, Hirano A, Hirai K, Seki S, Watanabe-Akanuma M. Activation of aryl hydrocarbon receptor mediates suppression of hypoxia-inducible factor-dependent erythropoietin expression by indoxyl sulfate. Am J Physiol Cell Physiol. 2016 Jan 15;310(2):C142\u201350.","journal-title":"Am J Physiol Cell Physiol"},{"key":"668_CR10","first-page":"14","volume":"4","author":"MS Ahmed","year":"2013","unstructured":"Ahmed MS, Abed M, Voelkl J, Lang F. Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate. BMC Nephrol. 2013 Nov;4:14\u2013244.","journal-title":"BMC Nephrol"},{"issue":"9","key":"668_CR11","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/ndt\/gfu061","volume":"29","author":"IW Wu","year":"2014","unstructured":"Wu IW, Hsu KH, Sun CY, Tsai CJ, Wu MS, Lee CC. Oral adsorbent AST-120 potentiates the effect of erythropoietin-stimulating agents on stage 5 chronic kidney disease patients: a randomized crossover study. Nephrol Dial Transplant. 2014 Sep;29(9):1719\u201327.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"668_CR12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0272-6386(99)70259-3","volume":"33","author":"J Gunnell","year":"1999","unstructured":"Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 1999 Jan;33(1):63\u201372.","journal-title":"Am J Kidney Dis"},{"key":"668_CR13","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.V451205","volume":"4","author":"JT Daugirdas","year":"1993","unstructured":"Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt\/V: an analysis of error. J Am Soc Nephrol. 1993;4:1205\u201313.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"668_CR14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2005090997","volume":"17","author":"DL Regidor","year":"2006","unstructured":"Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol. 2006 Apr;17(4):1181\u201391.","journal-title":"J Am Soc Nephrol"},{"key":"668_CR15","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1038\/ki.2008.523","volume":"111","author":"JM L\u00f3pez-G\u00f3mez","year":"2008","unstructured":"L\u00f3pez-G\u00f3mez JM, Portol\u00e9s JM, Aljama P. Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int Suppl. 2008 Dec;111:S75\u201381.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"668_CR16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.ajkd.2011.07.014","volume":"59","author":"S Fukuma","year":"2012","unstructured":"Fukuma S, Yamaguchi T, Hashimoto S, Nakai S, Iseki K, Tsubakihara Y, Fukuhara S. Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: results from a cohort study from the dialysis registry in Japan. Am J Kidney Dis. 2012 Jan;59(1):108\u201316.","journal-title":"Am J Kidney Dis"},{"key":"668_CR17","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jchromb.2011.06.014","volume":"879","author":"R Calaf","year":"2011","unstructured":"Calaf R, Cerini C, Genovesio C, Verhaeghe P, Jourde-Chiche N, Berg\u00e9-Lefranc D, Gondouin B, Dou L, Morange S, Argil\u00e9s A, Rathelot P, Dignat-George F, Brunet P, Charpiot P. Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay. J Chromatogr B. 2011;879:2281\u20136.","journal-title":"J Chromatogr B"},{"issue":"5","key":"668_CR18","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.ajkd.2015.07.015","volume":"66","author":"National Kidney Foundation","year":"2015","unstructured":"National Kidney Foundation. KDOQI clinical practice guideline for Hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015 Nov;66(5):884\u2013930.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"668_CR19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/blood.V47.4.561.561","volume":"47","author":"SF Wallner","year":"1976","unstructured":"Wallner SF, Kurnick JE, Ward HP, Vautrin R, Alfrey AC. The anemia of chronic renal failure and chronic diseases: in vitro studies of erythropoiesis. Blood. 1976 Apr;47(4):561\u20139.","journal-title":"Blood"},{"issue":"3","key":"668_CR20","first-page":"363","volume":"92","author":"SF Wallner","year":"1978","unstructured":"Wallner SF, Vautrin RM. The anemia of chronic renal failure: studies of the effect of organic solvent extraction of serum. J Lab Clin Med. 1978 Sep;92(3):363\u20139.","journal-title":"J Lab Clin Med"},{"issue":"10","key":"668_CR21","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1096\/fj.13-231837","volume":"27","author":"T Tanaka","year":"2013","unstructured":"Tanaka T, Yamaguchi J, Higashijima Y, Nangaku M. Indoxyl sulfate signals for rapid mRNA stabilization of Cbp\/p300-interacting transactivator with Glu\/asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia. FASEB J. 2013 Oct;27(10):4059\u201375.","journal-title":"FASEB J"},{"issue":"3","key":"668_CR22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.kint.2015.12.030","volume":"89","author":"L Dou","year":"2016","unstructured":"Dou L, Burtey S. The harmful effect of indoxyl sulfate on neovascularization in chronic kidney disease. Kidney Int. 2016 Mar;89(3):532\u20134.","journal-title":"Kidney Int"},{"key":"668_CR23","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2147\/TCRM.S120012","volume":"12","author":"JY Huang","year":"2016","unstructured":"Huang JY, Hsu CW, Yang CW, Hung CC, Huang WH. Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients. Ther Clin Risk Manag. 2016 Nov 28;12:1797\u2013803.","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"668_CR24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/toxins6030934","volume":"6","author":"M Sall\u00e9e","year":"2014","unstructured":"Sall\u00e9e M, Dou L, Cerini C, Poitevin S, Brunet P, Burtey S. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease. Toxins (Basel). 2014 Mar 4;6(3):934\u201349.","journal-title":"Toxins (Basel)"},{"issue":"9","key":"668_CR25","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1681\/ASN.2010121220","volume":"22","author":"PA Aronov","year":"2011","unstructured":"Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, Meyer TW. Colonic contribution to uremic solutes. J Am Soc Nephrol. 2011 Sep;22(9):1769\u201376.","journal-title":"J Am Soc Nephrol"},{"issue":"1\u20133","key":"668_CR26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000346628","volume":"35","author":"S Marzocco","year":"2013","unstructured":"Marzocco S, Dal Piaz F, Di Micco L, Torraca S, Sirico ML, Tartaglia D, Autore G, Di Iorio B. Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease. Blood Purif. 2013;35(1\u20133):196\u2013201.","journal-title":"Blood Purif"},{"issue":"1","key":"668_CR27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000186222","volume":"57","author":"T Niwa","year":"1991","unstructured":"Niwa T, Yazawa T, Ise M, Sugano M, Kodama T, Uehara Y, Maeda K. Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats. Nephron. 1991;57(1):84\u20138.","journal-title":"Nephron"}],"updated-by":[{"DOI":"10.1186\/s12882-017-0716-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T00:00:00Z","timestamp":1507075200000}}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0668-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T13:56:38Z","timestamp":1659275798000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0668-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0668-5","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12882-017-0716-1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]},"article-number":"251"}}